Prozac For Premenstrual Dysphoric Disorder May Get "Fem"-inine Touch
Executive Summary
Lilly is planning to market its blockbuster antidepressant Prozac (fluoxetine) with separate packaging and a new name for treatment of premenstrual dysphoric disorder.
You may also be interested in...
Lilly Sarafem PMDD Therapy Approved With Patient Package Insert
Lilly's pre-menstrual dysphoric disorder packaging for fluoxetine (Sarafem) will include a patient package insert.
Lilly Sarafem PMDD Therapy Approved With Patient Package Insert
Lilly's pre-menstrual dysphoric disorder packaging for fluoxetine (Sarafem) will include a patient package insert.
Lilly Fluoxetine For Premenstrual Dysphoria Merits Separate Indication
Labeling for Lilly's fluoxetine (Prozac) should include a separate indication for premenstrual dysphoric disorder, FDA's Psychopharmacologic Drugs Advisory Committee agreed Nov. 3.